- Published at
- by gurufocus.com
positive
positive
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
[url="]Cyclo Therapeutics, Inc.[/url] (Nasdaq: CYTH) (”Cyclo Therapeutics” or the ”Company”), a clinical stage biotechnology company dedicated to devel